Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations

Thomas Richard Porter, D. L. Eckberg, J. M. Fritsch, R. F. Rea, L. A. Beightol, J. F. Schmedtje, P. K. Mohanty

Research output: Contribution to journalArticle

173 Citations (Scopus)

Abstract

We conducted this study in an effort to characterize and understand vagal abnormalities in heart failure patients whose sympathetic activity is known. We measured sympathetic (peroneal nerve muscle sympathetic recordings and antecubital vein plasma norepinephrine levels) and vagal (R-R intervals and their standard deviations) activities in eight heart failure patients and eight age-matched healthy volunteers, before and after parasympathomimetic and parasympatholytic intravenous doses of atropine sulfate. At rest, sympathetic and parasympathetic outflows were related reciprocally: heart failure patients had high sympathetic and low parasympathetic outflows, and healthy subjects had low sympathetic and high parasympathetic outflows. Low dose atropine, which is known to increase the activity of central vagal-cardiac motoneurons, significantly increased R-R intervals in healthy subjects, but did not alter R-R intervals in heart failure patients. Thus, our data document reciprocal supranormal sympathetic and subnormal parasympathetic outflows in heart failure patients and suggest that these abnormalities result in part from abnormalities within the central nervous system.

Original languageEnglish (US)
Pages (from-to)1362-1371
Number of pages10
JournalJournal of Clinical Investigation
Volume85
Issue number5
DOIs
StatePublished - Jan 1 1990

Fingerprint

Cholinergic Agents
Heart Failure
Healthy Volunteers
Atropine
Parasympathomimetics
Parasympatholytics
Peroneal Nerve
Motor Neurons
Veins
Norepinephrine
Central Nervous System
Muscles

Keywords

  • atropine
  • microneurography
  • norepinephrine
  • parasympathetic
  • sinus arrhythmia
  • sympathetic

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Porter, T. R., Eckberg, D. L., Fritsch, J. M., Rea, R. F., Beightol, L. A., Schmedtje, J. F., & Mohanty, P. K. (1990). Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. Journal of Clinical Investigation, 85(5), 1362-1371. https://doi.org/10.1172/JCI114580

Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. / Porter, Thomas Richard; Eckberg, D. L.; Fritsch, J. M.; Rea, R. F.; Beightol, L. A.; Schmedtje, J. F.; Mohanty, P. K.

In: Journal of Clinical Investigation, Vol. 85, No. 5, 01.01.1990, p. 1362-1371.

Research output: Contribution to journalArticle

Porter, TR, Eckberg, DL, Fritsch, JM, Rea, RF, Beightol, LA, Schmedtje, JF & Mohanty, PK 1990, 'Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations', Journal of Clinical Investigation, vol. 85, no. 5, pp. 1362-1371. https://doi.org/10.1172/JCI114580
Porter, Thomas Richard ; Eckberg, D. L. ; Fritsch, J. M. ; Rea, R. F. ; Beightol, L. A. ; Schmedtje, J. F. ; Mohanty, P. K. / Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. In: Journal of Clinical Investigation. 1990 ; Vol. 85, No. 5. pp. 1362-1371.
@article{2f4e902530bc4fbca49a73e17c334436,
title = "Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations",
abstract = "We conducted this study in an effort to characterize and understand vagal abnormalities in heart failure patients whose sympathetic activity is known. We measured sympathetic (peroneal nerve muscle sympathetic recordings and antecubital vein plasma norepinephrine levels) and vagal (R-R intervals and their standard deviations) activities in eight heart failure patients and eight age-matched healthy volunteers, before and after parasympathomimetic and parasympatholytic intravenous doses of atropine sulfate. At rest, sympathetic and parasympathetic outflows were related reciprocally: heart failure patients had high sympathetic and low parasympathetic outflows, and healthy subjects had low sympathetic and high parasympathetic outflows. Low dose atropine, which is known to increase the activity of central vagal-cardiac motoneurons, significantly increased R-R intervals in healthy subjects, but did not alter R-R intervals in heart failure patients. Thus, our data document reciprocal supranormal sympathetic and subnormal parasympathetic outflows in heart failure patients and suggest that these abnormalities result in part from abnormalities within the central nervous system.",
keywords = "atropine, microneurography, norepinephrine, parasympathetic, sinus arrhythmia, sympathetic",
author = "Porter, {Thomas Richard} and Eckberg, {D. L.} and Fritsch, {J. M.} and Rea, {R. F.} and Beightol, {L. A.} and Schmedtje, {J. F.} and Mohanty, {P. K.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1172/JCI114580",
language = "English (US)",
volume = "85",
pages = "1362--1371",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",

}

TY - JOUR

T1 - Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations

AU - Porter, Thomas Richard

AU - Eckberg, D. L.

AU - Fritsch, J. M.

AU - Rea, R. F.

AU - Beightol, L. A.

AU - Schmedtje, J. F.

AU - Mohanty, P. K.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - We conducted this study in an effort to characterize and understand vagal abnormalities in heart failure patients whose sympathetic activity is known. We measured sympathetic (peroneal nerve muscle sympathetic recordings and antecubital vein plasma norepinephrine levels) and vagal (R-R intervals and their standard deviations) activities in eight heart failure patients and eight age-matched healthy volunteers, before and after parasympathomimetic and parasympatholytic intravenous doses of atropine sulfate. At rest, sympathetic and parasympathetic outflows were related reciprocally: heart failure patients had high sympathetic and low parasympathetic outflows, and healthy subjects had low sympathetic and high parasympathetic outflows. Low dose atropine, which is known to increase the activity of central vagal-cardiac motoneurons, significantly increased R-R intervals in healthy subjects, but did not alter R-R intervals in heart failure patients. Thus, our data document reciprocal supranormal sympathetic and subnormal parasympathetic outflows in heart failure patients and suggest that these abnormalities result in part from abnormalities within the central nervous system.

AB - We conducted this study in an effort to characterize and understand vagal abnormalities in heart failure patients whose sympathetic activity is known. We measured sympathetic (peroneal nerve muscle sympathetic recordings and antecubital vein plasma norepinephrine levels) and vagal (R-R intervals and their standard deviations) activities in eight heart failure patients and eight age-matched healthy volunteers, before and after parasympathomimetic and parasympatholytic intravenous doses of atropine sulfate. At rest, sympathetic and parasympathetic outflows were related reciprocally: heart failure patients had high sympathetic and low parasympathetic outflows, and healthy subjects had low sympathetic and high parasympathetic outflows. Low dose atropine, which is known to increase the activity of central vagal-cardiac motoneurons, significantly increased R-R intervals in healthy subjects, but did not alter R-R intervals in heart failure patients. Thus, our data document reciprocal supranormal sympathetic and subnormal parasympathetic outflows in heart failure patients and suggest that these abnormalities result in part from abnormalities within the central nervous system.

KW - atropine

KW - microneurography

KW - norepinephrine

KW - parasympathetic

KW - sinus arrhythmia

KW - sympathetic

UR - http://www.scopus.com/inward/record.url?scp=0025325138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025325138&partnerID=8YFLogxK

U2 - 10.1172/JCI114580

DO - 10.1172/JCI114580

M3 - Article

VL - 85

SP - 1362

EP - 1371

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 5

ER -